Location History:
- Sharon, MA (US) (2018)
- Boston, MA (US) (2021 - 2022)
Company Filing History:
3 out of 1,556 
1 out of 1,210 
1 out of 975 
Years Active: 2018-2022
Title: Innovations and Contributions of Inventor Wei Zhang
Introduction
Wei Zhang is a prominent inventor based in Boston, MA, known for his significant contributions to the field of pharmaceutical sciences. With a total of three patents to his name, he has made notable advancements in the development of small molecule inhibitors that target transcription factors.
Latest Patents
Wei Zhang's latest patents include innovative compounds designed to enhance therapeutic outcomes. One of his patents focuses on small molecule inhibitors for transcription factors, providing compounds of Formula (I) and their pharmaceutically acceptable salts. This patent also discloses related pharmaceutical compositions and methods of treatment utilizing these compounds. Another significant patent involves certain imidazopyridines as cyclic AMP response element binding (CREB) binding protein (CBP) inhibitors. This disclosure relates to compounds that act as CBP inhibitors and outlines methods for their use in the treatment and diagnosis of various diseases and disorders.
Career Highlights
Throughout his career, Wei Zhang has worked with esteemed institutions such as the University of Massachusetts and Dana-Farber Cancer Institute. His work in these organizations has allowed him to collaborate on groundbreaking research and contribute to advancements in cancer treatment.
Collaborations
Wei Zhang has collaborated with notable colleagues, including Jason J Marineau and James Elliott Bradner. These partnerships have further enriched his research and innovation efforts.
Conclusion
Wei Zhang's contributions to the field of pharmaceutical sciences through his patents and collaborations highlight his role as a leading inventor. His work continues to impact the development of new therapeutic strategies.